Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide effects on intracranial pressure in glaucoma
NL-OMON48559Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of acetazolamide in Glaucoma and open-angle glaucoma (OAG) (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Peak intracranial pressure, Trough intracranial pressure and 2 more. Started May 2019; status: active, not recruiting.
02
Drugs
acetazolamide
03
Conditions
Glaucomaopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on NL-OMON48559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48559.